ERBB2 and breast cancer: Most of the patients with lymph node metastasis were affected by TNBC (n = 6; 30%) and HER-2 positive BC (n = 9; 45%), while only 5 patients (20%) with Luminal A or Luminal B BC had nodal involvement.